Suppr超能文献

图像引导调强放射治疗与前列腺癌患者 3D 适形放射治疗后的急性毒性比较。

Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.

机构信息

Department of Radiation Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.

Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):737-44. doi: 10.1016/j.ijrobp.2014.12.017.

Abstract

PURPOSE

Image-guided intensity modulated radiation therapy (IG-IMRT) allows significant dose reductions to organs at risk in prostate cancer patients. However, clinical data identifying the benefits of IG-IMRT in daily practice are scarce. The purpose of this study was to compare dose distributions to organs at risk and acute gastrointestinal (GI) and genitourinary (GU) toxicity levels of patients treated to 78 Gy with either IG-IMRT or 3D-CRT.

METHODS AND MATERIALS

Patients treated with 3D-CRT (n=215) and IG-IMRT (n=260) receiving 78 Gy in 39 fractions within 2 randomized trials were selected. Dose surface histograms of anorectum, anal canal, and bladder were calculated. Identical toxicity questionnaires were distributed at baseline, prior to fraction 20 and 30 and at 90 days after treatment. Radiation Therapy Oncology Group (RTOG) grade ≥1, ≥2, and ≥3 endpoints were derived directly from questionnaires. Univariate and multivariate binary logistic regression analyses were applied.

RESULTS

The median volumes receiving 5 to 75 Gy were significantly lower (all P<.001) with IG-IMRT for anorectum, anal canal, and bladder. The mean dose to the anorectum was 34.4 Gy versus 47.3 Gy (P<.001), 23.6 Gy versus 44.6 Gy for the anal canal (P<.001), and 33.1 Gy versus 43.2 Gy for the bladder (P<.001). Significantly lower grade ≥2 toxicity was observed for proctitis, stool frequency ≥6/day, and urinary frequency ≥12/day. IG-IMRT resulted in significantly lower overall RTOG grade ≥2 GI toxicity (29% vs 49%, respectively, P=.002) and overall GU grade ≥2 toxicity (38% vs 48%, respectively, P=.009).

CONCLUSIONS

A clinically meaningful reduction in dose to organs at risk and acute toxicity levels was observed in IG-IMRT patients, as a result of improved technique and tighter margins. Therefore reduced late toxicity levels can be expected as well; additional research is needed to quantify such reductions.

摘要

目的

图像引导调强放疗(IG-IMRT)可显著降低前列腺癌患者的风险器官的剂量。然而,在临床实践中,识别 IG-IMRT 益处的临床数据却很少。本研究的目的是比较接受 78Gy 照射的患者采用 IG-IMRT 或 3D-CRT 的风险器官剂量分布和急性胃肠道(GI)和泌尿生殖系统(GU)毒性水平。

方法和材料

选择在 2 项随机试验中接受 3D-CRT(n=215)和 IG-IMRT(n=260)治疗,接受 78Gy/39 次分割的患者。计算直肠肛门、肛管和膀胱的剂量表面直方图。在基线、第 20 和 30 次分割前以及治疗后 90 天,发放相同的毒性问卷。根据问卷直接得出放射治疗肿瘤学组(RTOG)≥1、≥2 和≥3 终点。采用单变量和多变量二元逻辑回归分析。

结果

与 IG-IMRT 相比,接受 5 至 75Gy 的直肠肛门、肛管和膀胱的中位体积明显较低(均 P<.001)。直肠肛门的平均剂量为 34.4Gy 比 47.3Gy(P<.001),肛管为 23.6Gy 比 44.6Gy(P<.001),膀胱为 33.1Gy 比 43.2Gy(P<.001)。观察到直肠炎、大便频率≥6/天和尿频率≥12/天的≥2 级毒性明显较低。IG-IMRT 导致明显较低的总体 RTOG≥2 级 GI 毒性(分别为 29%和 49%,P=.002)和总体 GU≥2 级毒性(分别为 38%和 48%,P=.009)。

结论

由于技术的改进和更严格的边界,IG-IMRT 患者的风险器官剂量和急性毒性水平显著降低。因此,预计晚期毒性水平也会降低;需要进一步的研究来量化这种降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验